Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ashley H. Sanderlin"'
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 8, Iss 1, Pp n/a-n/a (2022)
Abstract Introduction Sleep and diet are modifiable risk factors for Alzheimer's disease (AD) that may be salient areas for the development of preventive intervention strategies against dementia in people with mild cognitive impairment (MCI). Sleep d
Externí odkaz:
https://doaj.org/article/27cd4ec0c9ba43a38d6c9f89fe7b6328
Publikováno v:
Frontiers in Aging Neuroscience, Vol 9 (2017)
Externí odkaz:
https://doaj.org/article/c6506274d78d4d71ae765969338b6612
Publikováno v:
Frontiers in Aging Neuroscience, Vol 9 (2017)
Background: Neuropsychiatric symptoms (NPSs) in MCI, and midlife obesity increase the likelihood of developing Alzheimer’s disease. It is unknown whether obesity or related health conditions modify the risk of NPS or severity of cognitive impairmen
Externí odkaz:
https://doaj.org/article/6f33b731064e49cb9b716c0acd8128ef
Autor:
Ashley H. Sanderlin, Samuel N. Lockhart, Kathleen M. Hayden, Suzanne Craft, Mia Yang, Bonnie C. Sachs, Maryjo Cleveland, Benjamin J. Williams, Jeff D. Williamson, James R. Bateman
Publikováno v:
Alzheimer's & Dementia. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1ca8225e853460ac59714b3622606ba
https://doi.org/10.1002/alz.069378
https://doi.org/10.1002/alz.069378
Autor:
Laura D. Baker, James B. Leverenz, Ashley H. Sanderlin, Siobhan M. Hoscheidt, Suzanne Craft, Angela J. Hanson, Seth D. Friedman, Youngkyoo Jung, Samuel N. Lockhart, Thomas C. Register, Christopher T. Whitlow, Derek Kellar
Publikováno v:
Alzheimer's & Dementia. 18:457-468
Introduction Mid-life dietary patterns are associated with Alzheimer's disease (AD) risk, although few controlled trials have been conducted. Methods Eighty-seven participants (age range: 45 to 65) with normal cognition (NC, n = 56) or mild cognitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0d3b13d600e629e842abdc6719ac11
https://doi.org/10.1002/alz.12421
https://doi.org/10.1002/alz.12421
Publikováno v:
Alzheimer's & Dementia. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a33705bc78f2c708d8846cef3bf6edc6
https://doi.org/10.1002/alz.057471
https://doi.org/10.1002/alz.057471
Autor:
Kathleen M Hayden, Adam P Spira, Marie‐Pierre St‐Onge, Jingzhong Ding, Andrea Anderson, Doris P Molina‐Henry, Ashley H Sanderlin, David M Reboussin, Mark A Espeland, Judy Bahnson
Publikováno v:
Alzheimer's & Dementia. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8b5fbe429117a162f944e94652de8f3
https://doi.org/10.1002/alz.051185
https://doi.org/10.1002/alz.051185
Autor:
Sharon L. Edelstein, Mark A. Espeland, Elena Barengolts, Suzanne Craft, Ashley H. Sanderlin, Amy Claxton, Philip Zeitler, Silva A. Arslanian, Mark Tripputi, Babak Mokhlesi, Kristen J. Nadeau, Kieren J. Mather, Tamara S. Hannon, Karla A. Temple, Steven E. Kahn
Publikováno v:
Diabetes. 69
In cross-sectional studies, adolescents with T2D show poorer cognition than normoglycemic youth. In the Restoring Insulin Secretion (RISE) Study, we assessed longitudinal relationships between insulin sensitivity, β-cell function and cognition in 72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13623c2819cbb7b75dd049c6d68ef505
https://doi.org/10.2337/db20-1268-p
https://doi.org/10.2337/db20-1268-p
Publikováno v:
Alzheimer's & Dementia. 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d75dc5dfc7f9d478927c1e00d61e7417
https://doi.org/10.1016/j.jalz.2019.09.044
https://doi.org/10.1016/j.jalz.2019.09.044
Autor:
Babak Mokhlesi, Karla A. Temple, Ashley H. Sanderlin, Sharon L. Edelstein, Silva A. Arslanian, Kieren J. Mather, Mark A. Espeland, Amy Claxton, Kristen J. Nadeau, Mark Tripputi, Suzanne Craft, Philip Zeitler
Publikováno v:
Diabetes. 68
Insulin resistance and impaired β-cell function are associated with risk of cognitive decline in adults over 65 y of age. Their impact on cognition in youth and adults 25 mmol/L. The cognitive battery (CogStateTM and story recall) assessed 1) psycho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10c7c5213822c0e50f9ebc35560463a0
https://doi.org/10.2337/db19-1561-p
https://doi.org/10.2337/db19-1561-p